? Class 4 medicines defect information: Aripiprazole 1mg/ml oral solution


Mylan UK Healthcare Ltd has informed the MHRA that a product complaint has been received relating to crystalline precipitate being observed during bottle use. Due to concerns with continuity of supply these batches are not being recalled at this time.


Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [68.20 KB]


This circular is being shared under the Open Government Copyright licence. Whilst we will publish alerts relevant to pharmacists, pharmacy technicians and pharmacy teams we recommend you also keep an eye on the SHOW website.



Published by

PIP editor

A pharmacist led training provider.

Leave a Reply

Your email address will not be published.